Delivery Order SPE2DR25D1053-SPE2DR26FT341
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Cibinqo 100 mg tablets (30-count units) with a ceiling value of $8,673.50. This competitively awarded, firm fixed-price delivery order is classified as a child contract, indicating it derives from a larger contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of October 22, 2025....
- The Defense Logistics Agency awarded a $4,060.89 delivery order to AmerisourceBergen Drug Corp for CIBINQO 100 mg tablets (30-count units) with a completion deadline of July 9, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is being performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $4,038.72 on October 6, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which is not set-aside restricted, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The vendor, headquartered in Conshohocken, Pennsylvania, will...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp (CAGE 0U9U0) on October 20, 2025, for a ceiling value of $10,750.82. This firm fixed price delivery order, which is expected to be completed by October 21, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was made on a competitive basis without set-aside designation, reflecting...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,699.83 to AmerisourceBergen Drug Corp (CAGE 0U9U0) on October 1, 2025. This non-competitive, firm fixed-price delivery order is scheduled for completion by October 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves as the...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,776.36 by the Defense Logistics Agency's Medical Supply Chain on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The award was made through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,699.50 by the Defense Logistics Agency's Medical Supply Chain on September 11, 2025. This firm fixed-price delivery order, with a completion date of September 12, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a firm fixed price delivery order valued at $8,740.47 from the Defense Logistics Agency's Medical Supply Chain on October 20, 2025. The delivery order, which represents a child contract under AmerisourceBergen's broader federal pharmaceutical supply agreement, carries an ultimate completion date of October 21, 2025. This award was made through open competition without set-aside...
- This delivery order, awarded October 13, 2025, represents a $33,832.92 firm fixed-price contract issued by the Defense Logistics Agency's Medical Supply Chain to AmerisourceBergen Drug Corp (CAGE 0U9U0), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The contract is a child order under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $45,278.31 on July 28, 2025, by the Defense Logistics Agency's Medical Supply Chain with a completion date of July 29, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- SPE2DR25D1053Indefinite Delivery Contract
- SPE2DR25D1053-SPE2DR26FT341Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 27, 2025, for the supply of Cibinqo 100 mg tablets in quantities of 30 units, with a ceiling value of $5,114.08. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of October 28, 2025. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999.999 billion through December 2026. As a prime pharmaceutical vendor for the Defense Logistics Agency's Medical Supply Chain, AmerisourceBergen supplies a comprehensive range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military and veteran healthcare systems. The company's role as a critical federal medical procurement vendor demonstrates its established capability to meet federal requirements for pharmaceutical distribution across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 10/27/25 |